Skip to content
sellNotable cluster of 6

Timothy Schmid sold $5.5M of JNJ

EVP, WW Chair, MedTech at JOHNSON & JOHNSON. 22,623 shares at an average of $244.33, traded Feb 18, 2026, filed Feb 18, 2026.

Warning score
65
Value
$5.5M
22,623 shares
Holdings after
26,769
-56% from before
From 52-week low
+71%
low $140.88, close $241.11
From 52-week high
0%
high $241.11, as of Feb 18, 2026

Score components

  • Role
    Chair
    +20
  • Trade size
    $5.5M at market
    +25
  • Share of holdings sold
    Sold 56% of holdings
    +20
  • Cluster
    6 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -3.4%, 3m -5.9%, 6m +12.8%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

JNJOct 13, 2026 · close 248.61
Since filing Feb 18, 2026: +3.1%SPY +14.3% · excess -11.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000200406-26-000036, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Feb 13, 2026MOption exercise
Common Stock
+499$0.00$022,624Feb 18, 2026
Feb 13, 2026FTax withholding
Common Stock
-8$244.55$1,95622,616Feb 18, 2026
Feb 13, 2026MOption exercise
Common Stock
+4,378$0.00$026,994Feb 18, 2026
Feb 13, 2026FTax withholding
Common Stock
-1,816$244.55$444k25,178Feb 18, 2026
Feb 15, 2026MOption exercise
Common Stock
+1,028$0.00$026,206Feb 18, 2026
Feb 15, 2026FTax withholding
Common Stock
-15$243.45$3,65226,191Feb 18, 2026
Feb 15, 2026MOption exercise
Common Stock
+1,026$0.00$027,217Feb 18, 2026
Feb 15, 2026FTax withholding
Common Stock
-448$243.45$109k26,769Feb 18, 2026
Feb 18, 2026MOption exercise
Common Stock
+13,625$115.67$1.6M40,394Feb 18, 2026
Feb 18, 2026SOpen-market sale
Common Stock
-13,625$244.20$3.3M26,769Feb 18, 2026
Feb 18, 2026MOption exercise
Common Stock
+8,998$129.51$1.2M35,767Feb 18, 2026
Feb 18, 2026SOpen-market sale
Common Stock
-8,998$244.53$2.2M26,769Feb 18, 2026
Feb 13, 2026MOption exercise
Restricted Share Unitsderivative
-499$0.00$00Feb 18, 2026
Feb 13, 2026MOption exercise
Performance Share Unitsderivative
-4,378$0.00$00Feb 18, 2026
Feb 15, 2026MOption exercise
Restricted Share Unitsderivative
-1,028$0.00$01,028Feb 18, 2026
Feb 15, 2026MOption exercise
Restricted Share Unitsderivative
-1,026$0.00$02,051Feb 18, 2026
Feb 15, 2026AGrant or award
Employee Stock Options (Right to Buy)derivative
+35,489$0.00$035,489Feb 18, 2026
Feb 15, 2026AGrant or award
Restricted Share Unitsderivative
+2,548$0.00$02,548Feb 18, 2026
Feb 18, 2026MOption exercise
Employee Stock Options (Right to Buy)derivative
-13,625$0.00$00Feb 18, 2026
Feb 18, 2026MOption exercise
Employee Stock Options (Right to Buy)derivative
-8,998$0.00$00Feb 18, 2026

Related signals

Other insiders at JOHNSON & JOHNSON and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
50Moderate
JNJsell
JOHNSON & JOHNSON
Timothy Schmid
EVP, WW Chair, MedTech
$9.2M
33,597 shares
-92%
40Moderate
JNJsell 3
JOHNSON & JOHNSON
Jennifer L Taubert
EVP, WWC. Innovative Medicine
$4.0M
15,000 shares
-7%
60Notable
JNJsell 3
JOHNSON & JOHNSON
Joaquin Duato
CEO and Chairman of the Board
$32M
123,291 shares
-31%
70Notable
JNJsell 3
JOHNSON & JOHNSON
Joaquin Duato
CEO and Chairman of the Board
$13M
48,480 shares
-15%
50Moderate
JNJsell 3
JOHNSON & JOHNSON
Elizabeth Forminard
EVP, Chief Legal Officer
$4.1M
15,918 shares
-48%
45Moderate
JNJsell
JOHNSON & JOHNSON
Vanessa Broadhurst
EVP, Global Corp Affairs
$5.8M
23,054 shares
-50%
25Weak
JNJsell
JOHNSON & JOHNSON
Kathryn E Wengel
EVP, Chief TO and Risk Officer
$2.4M
10,000 shares
-8%
45Moderate
JNJsell 6
JOHNSON & JOHNSON
Robert J Decker
VP Corporate Controller
$1.0M
4,075 shares
-15%
49Moderate
JNJsell 6
JOHNSON & JOHNSON
Timothy Schmid
EVP, WW Chair, MedTech
$325k
1,322 shares
-5%
45Moderate
JNJsell 6
JOHNSON & JOHNSON
Vanessa Broadhurst
EVP, Global Corp Affairs
$1.5M
6,197 shares
-21%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Timothy Schmid sold $5.5M of JNJ | InsiderTell